These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31175377)

  • 61. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
    Raitanen MP;
    World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
    Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
    Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
    Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Bladder cancer biomarkers].
    Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
    Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bladder cancer recurrence surveillance by urine metabolomics analysis.
    Loras A; Trassierra M; Sanjuan-Herráez D; Martínez-Bisbal MC; Castell JV; Quintás G; Ruiz-Cerdá JL
    Sci Rep; 2018 Jun; 8(1):9172. PubMed ID: 29907864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
    Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
    Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
    Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Jinzaki M; Kikuchi E; Akita H; Sugiura H; Shinmoto H; Oya M
    Int J Urol; 2016 Apr; 23(4):284-98. PubMed ID: 26750188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Rational follow-up of non-muscle invasive bladder cancer].
    von Landenberg N; Benderska-Söder N; Bismarck E; Kernig K; Erne E; Goebell PJ; Schmitz-Dräger BJ
    Urologe A; 2021 Nov; 60(11):1409-1415. PubMed ID: 34652477
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis.
    Lykke MR; Nielsen TK; Ebbensgaard NA; Zieger K
    Scand J Urol; 2015 Jun; 49(3):230-6. PubMed ID: 25731785
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.
    Schwalb MD; Herr HW; Sogani PC; Russo P; Sheinfeld J; Fair WR
    J Urol; 1994 Aug; 152(2 Pt 1):382-7. PubMed ID: 8015076
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-muscle-Invasive Bladder Cancer.
    Lotan Y; Baky FJ
    Urol Clin North Am; 2023 Feb; 50(1):53-67. PubMed ID: 36424083
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
    Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
    Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Follow-up of urothelial carcinoma: Review of the Cancer Committee of the French Association of Urology].
    Colin P; Neuzillet Y; Pignot G; Rouprêt M; Comperat E; Larré S; Roy C; Quintens H; Houedé N; Soulié M; Pfister C;
    Prog Urol; 2015 Sep; 25(10):616-24. PubMed ID: 26141291
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Suprapubic bladder ultrasonography and urinary cytology: indications and limits in the follow-up of superficial bladder tumors].
    Pegoraro C; Bondavalli C; Molani L; Capitanio A; Schiavon L; Dall'Oglio B; Luciano M; Negri S
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63 Suppl 2():127-9. PubMed ID: 1836650
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
    Halachmi S; Moskovitz B; Maffezzini M; Conti G; Verweij F; Kedar D; Sandri SD; Nativ O; Colombo R
    Urol Oncol; 2011; 29(3):259-64. PubMed ID: 19395285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.